| Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute … C Niu, H Yan, T Yu, HP Sun, JX Liu, XS Li, W Wu, FQ Zhang, Y Chen, ... Blood, The Journal of the American Society of Hematology 94 (10), 3315-3324, 1999 | 819 | 1999 |
| Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia J Hu, YF Liu, CF Wu, F Xu, ZX Shen, YM Zhu, JM Li, W Tang, WL Zhao, ... Proceedings of the National Academy of Sciences 106 (9), 3342-3347, 2009 | 548 | 2009 |
| NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis YM Zhu, WL Zhao, JF Fu, JY Shi, Q Pan, J Hu, XD Gao, B Chen, JM Li, ... Clinical cancer research 12 (10), 3043-3049, 2006 | 198 | 2006 |
| Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial J Jin, JX Wang, FF Chen, DP Wu, J Hu, JF Zhou, JD Hu, JM Wang, JY Li, ... The lancet oncology 14 (7), 599-608, 2013 | 173 | 2013 |
| The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China Y Wang, H Chen, J Chen, M Han, JD Hu, J Hu, H Huang, Y Lai, D Liu, ... Cancer Letters 438, 63-75, 2018 | 141 | 2018 |
| The simpler, the better: oral arsenic for acute promyelocytic leukemia HH Zhu, J Hu, F Lo-Coco, J Jin Blood, The Journal of the American Society of Hematology 134 (7), 597-605, 2019 | 131 | 2019 |
| Effect of rhG-CSF combined with decitabine prophylaxis on relapse of patients with high-risk MRD-negative AML after HSCT: an open-label, multicenter, randomized controlled trial L Gao, Y Zhang, S Wang, P Kong, Y Su, J Hu, M Jiang, H Bai, T Lang, ... Journal of Clinical Oncology 38 (36), 4249-4259, 2020 | 129 | 2020 |
| Arsenic in cancer therapy J Hu, J Fang, Y Dong, SJ Chen, Z Chen Anti-Cancer Drugs 16 (2), 119-127, 2005 | 123 | 2005 |
| Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients JY Shi, ZZ Shi, SJ Zhang, YM Zhu, BW Gu, G Li, XT Bai, XD Gao, J Hu, ... Pharmacogenetics and Genomics 14 (11), 759-768, 2004 | 104 | 2004 |
| Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: a multicenter, open-label, randomized controlled study YJ Chang, DP Wu, YR Lai, QF Liu, YQ Sun, J Hu, Y Hu, JF Zhou, J Li, ... Journal of Clinical Oncology 38 (29), 3367-3376, 2020 | 103 | 2020 |
| Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes W Gu, J Hu, W Wang, L Li, W Tang, S Sun, W Cui, L Ye, Y Zhang, J Hong, ... Diabetes care 35 (7), 1413-1419, 2012 | 102 | 2012 |
| Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single … J Hu, ZX Shen, GL Sun, SJ Chen, ZY Wang, Z Chen International journal of hematology 70 (4), 248-260, 1999 | 101 | 1999 |
| Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia L Xu, WL Zhao, SM Xiong, XY Su, M Zhao, C Wang, YR Gao, C Niu, ... Leukemia 15 (9), 1359-1368, 2001 | 97 | 2001 |
| Prevalence of resistant gram-negative bacilli in bloodstream infection in febrile neutropenia patients undergoing hematopoietic stem cell transplantation: a single center … L Wang, Y Wang, X Fan, W Tang, J Hu Medicine 94 (45), e1931, 2015 | 93 | 2015 |
| FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia J Long, MY Jia, WY Fang, XJ Chen, LL Mu, ZY Wang, Y Shen, RF Xiang, ... Blood, The Journal of the American Society of Hematology 135 (17), 1472-1483, 2020 | 75 | 2020 |
| Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response J Long, WY Fang, L Chang, WH Gao, Y Shen, MY Jia, YX Zhang, Y Wang, ... Leukemia 31 (12), 2761-2770, 2017 | 75 | 2017 |
| The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia H Zhu, J Hu, LI Chen, W Zhou, X Li, L Wang, X Zhao, Y Zhang, H Zhao, ... Blood, The Journal of the American Society of Hematology 128 (11), 1525-1528, 2016 | 68 | 2016 |
| Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial) L Chen, HM Zhu, Y Li, QF Liu, Y Hu, JF Zhou, J Jin, JD Hu, T Liu, DP Wu, ... Proceedings of the National Academy of Sciences 118 (6), e2020382118, 2021 | 53 | 2021 |
| Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient X Zhang, L Ye, J Hu, W Tang, R Liu, M Yang, J Hong, W Wang, G Ning, ... PLoS One 7 (2), e31887, 2012 | 51 | 2012 |
| Mutations of epigenetic modifier genes as a poor prognostic factor in acute promyelocytic leukemia under treatment with all-trans retinoic acid and arsenic trioxide Y Shen, YK Fu, YM Zhu, YJ Lou, ZH Gu, JY Shi, B Chen, C Chen, HH Zhu, ... EBioMedicine 2 (6), 563-571, 2015 | 49 | 2015 |